Error message

The page you requested does not exist. For your convenience, a search was performed using the query about us interactive decision month.

Page not found

You are here

Mon, January 05, 2015

Reshma Jagsi was interviewed by mCancerTalk for the article, “Is your course of radiation treatment longer than it needs to be?” which focuses on two of her radiation treatment studies. In one of her studies, looking at a national database of patients, she and her colleagues found that hypofractionated radiation therapy was used in only 13.6% of Medicare patients with breast cancer. In Michigan, Jagsi’s other study found, fewer than one-third of patients who fit the criteria for offering this approach got the shorter course of treatment.

Read Dr. Jagsi’s paper about hypofractionation use nationally and in Michigan.

Geoffrey Barnes is lead author on study published in the American Journal of Medicine finding new anticoagulants are driving increase in atrial fibrillation treatment and reducing warfarin therapy use.

“The data provides a promising outlook about atrial fibrillation which is known for being undertreated,” says lead author Geoffrey Barnes, M.D., MSc.,  cardiologist at the University of Michigan Health System and researcher at the Institute for Healthcare Policy and Innovation.  “When we don’t treat atrial fibrillation, patients are at risk for stroke. By seeking treatment, patients set themselves up for better outcomes.”

More details can be found here.

CBSSM Seminar: Stephen Molldrem, PhD Candidate

Thu, July 07, 2016, 3:00pm
Location: 
NCRC Building 16, Conference Rm 266C

Stephen Molldrem, PhD Candidate, American Culture

Title: Collecting and Managing Sexual Orientation and Gender Identity Data in Health Contexts: Bioethical Dilemmas from a Queer Historical Perspective

Abstract: This talk, drawn from dissertation research, historicizes a number of regulatory changes governing the collection and management of sexual orientation and gender identity data in health contexts in the United States that have taken place since 2009. It focuses on a range of less-considered bioethical dilemmas that stem from the introduction of questions about sexual orientation and gender identity into the battery of demographic information collected in certified Electronic Health Record technologies.

Attitudes toward Return of Secondary Results in Genomic Sequencing (Sep-16)

Imagine you are at the doctor’s office because you (or your child) have a serious health condition like heart disease or cancer. To help find out whether any treatment options exist, your doctor suggests that you (or your child) have your genome sequenced.

Genome sequencing may provide information about your (or your child’s) current health condition. However, the genome sequencing could reveal additional and unexpected results not related to the current condition. The doctor wants to know what types of these secondary results you would want to be told.

Thu, July 14, 2016

A new article in The Conversation authored by CBSSM Co-Director Raymond De Vries and colleague Tom Tomlinson from Michigan State University explores ethical concerns that may arise when patients donate blood and tissue samples to biobanks.

The article highlights results from their national survey, which indicated that respondents were not solely concerned with privacy, but had moral concerns about how their donations could be used in future research.

Wed, May 18, 2016

Reshma Jagsi’s survey of high-achieving physician-scientists published in JAMA, found that nearly a third of women reported experiencing sexual harassment. As women now make up about half of medical school students, the researchers emphasize the importance of recognizing unconscious bias as well as overtly inappropriate behaviors.

1. Reshma Jagsi, Kent A. Griffith, Rochelle Jones, Chithra R. Perumalswami, Peter Ubel, Abigail Stewart. Sexual Harassment and Discrimination Experiences of Academic Medical Faculty. JAMA, 2016; 315 (19): 2120 DOI: 10.1001/jama.2016.2188

Research Topics: 

Raymond De Vries is involved in a new research study led by Akbar Waljee, MD, MSc, which will develop a risk-based strategy to help providers tailor timing of treatments among CHC Veterans to ensure that those who most need urgent therapy get it as quickly as possible.

Using democratic deliberation, Dr. De Vries will engage Veterans to learn their thoughts and preferences about such a strategy, which will help with its implementation in a clinical setting.

Click here for more details.

Mon, January 30, 2017

Kayte Spector-Bagdady has a new commentary out in The Conversation about the law and ethics of research with human biospecimens. It focuses on the recently published revisions to the human subjects research regulations, highlights the debate that ensued from a draft version over its proposal to include nonidentified biospecimens in its definition of "human subject," and summarizes where the final rule landed and possible steps going forward.

Research Topics: 

Panel Discussion: Ethical, Legal, and Social Implications of Genetics and Newborn Screening

Mon, September 25, 2017, 6:00pm
Location: 
Vandenberg Room, Michigan League

Join Joselin Linder, author of “The Family Gene”, and Jodyn Platt, assistant professor in the U-M Medical School in a panel discussion about the ethical, legal, and social implications of genetics and newborn screening. The conversation will be moderated by Kayte Spector-Bagdady, assistant professor in the U-M Medical School and chief of the research ethics service in the Center for Bioethics and Social Sciences in Medicine.

Wed, October 11, 2017

In an editorial in Nature Human Behaviour, Brian Zikmund-Fisher discusses the findings of a recent study about the unintended consequences of argument dilution in direct-to-consumer drug advertising. In a series of experiments, study authors, Niro Sivanathan and Hemant Kakker found that long lists of serious and minor side effects found in drug advertisements actually "dilute" consumers' judgments of the overall risk from side effects.

Pages